Severe Acute Respiratory Syndrome Treatment Market

Severe Acute Respiratory Syndrome Treatment Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment; 2018 - 2028

  • Ongoing
  • June 2020
  • REP-GB-6866
  • PDF PPT EXCEL
Severe Acute Respiratory Syndrome Treatment Market
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This Severe Acute Respiratory Syndrome Treatment market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Severe Acute Respiratory Syndrome Treatment market.


The severe acute respiratory syndrome is caused by the coronavirus which is found in bats and palm civets in Southern China. The severe acute respiratory syndrome is a serious life-threatening viral infection. Its symptoms includes cough, chills and shaking, headache, muscle aches, diarrhea, nausea, vomiting and dizziness. The severe acute respiratory syndrome first appeared in 2003 and spread rapidly. This infection can spread easily from one person to another via respiratory droplets if they come in contact with skin or mucous membranes. In October 2012, the severe acute respiratory infection was added to National Select Agent Registry, which regulates the handling and control of bacteria, viruses and toxins that have the capability to pose a severe risk to public health and safety. Risk of atypical pneumonia, pulmonary fibrosis and respiratory failure are the major risk factors associated with the severe acute respiratory syndrome. Antivirals and antibiotics are recommended for treatment of severe acute respiratory syndrome. However, an antibiotic treatment, in most cases, is not enough to treat severe acute respiratory syndrome treatment; supportive care is also required.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Severe Acute Respiratory Syndrome Treatment Market: Drivers and Restraints-

Risk factors associated with the spread of severe acute respiratory syndrome include increasing recommendation for combination therapy drugs and increasing prevalence of infectious diseases. These factors will drive the growth of the severe acute respiratory syndrome treatment market. 90% cases of severe acute respiratory syndrome in developing countries and increasing complication rate due to pneumonia and respiratory failures will propel the growth of the severe acute respiratory syndrome treatment market during the forecast period. Increasing research and development and clinical trial and usage of therapeutics for severe acute respiratory syndrome treatment will propel the growth of severe acute respiratory syndrome treatment market. Government initiatives to reduce mortality rate will also be a major factor which will contribute to the growth of the severe acute respiratory syndrome treatment market.

Severe Acute Respiratory Syndrome Treatment Market: Overview

Severe acute respiratory syndrome treatment therapeutic drugs involve a broad-spectrum of antibiotics and supportive care as well as immunomodulatory therapy and antiviral agents. Some antibiotics have immunomodulatory properties. For instance, quinolones and macrolides are prescribed for severe acute respiratory syndrome treatment. The Ribavirin antiviral drug was majorly chosen as an empirial therapy for severe acute respiratory syndrome. It is the most commonly used antiviral with corticosteroids. Corticosteroids have been the main immunomodulatory therapy used for severe acute respiratory syndrome treatment. Thymosin alpha 1 is also administrated to treat severe acute respiratory syndrome treatment, especially in China. Thymosin alpha 1 is a relatively safe product and enhances T-cell function.

Severe Acute Respiratory Syndrome Treatment Market: Region-wise Outlook

In terms of geography, the severe acute respiratory syndrome treatment market has been divided into seven regions -- North- America, Eastern Europe, Western Europe and Asia- Pacific excluding China & Japan (APECJ), Japan Middle-East & Africa and Latin America. North America is the dominating segment in the severe acute respiratory syndrome treatment market due to rising awareness regarding infectious diseases and increasing drug manufacturing facilities. In Western Europe, Germany, France and the UK will be the fastest growing regions in the severe acute respiratory syndrome treatment market due to strengthening laws and government guidelines covering infectious diseases. APEJ region includes two fastest developing countries -- India and China -- which will prove to be the most promising markets for severe acute respiratory syndrome treatment market players due to factors like increasing government initiatives to reduce disease complication and high incidences of diseases in China.

Severe Acute Respiratory Syndrome Treatment Market: Key Market Participants

Example of some key market participants in the global severe acute respiratory syndrome treatment market are Novartis AG, Pfizer Inc., Johnson & Johnson, GlaxoSmithKline PLC., Reckitt Benckiser Group plc, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Merck & Company, Inc., Abbott Laboratories and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, ASEAN, Australia & New Zealand)
  • China
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Severe Acute Respiratory Syndrome Treatment Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Severe Acute Respiratory Syndrome Treatment Market: Segmentation

On the basis of drug type, the severe acute respiratory syndrome treatment market can be segmented into:

  • Antiviral
  • Antibacterial
  • Immunomodulators drugs

On the basis of route of administration, the severe acute respiratory syndrome treatment market can be segmented into:

  • Oral
  • Injectable

On the basis of distribution channel, the market can be segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Severe Acute Respiratory Syndrome Treatment Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Severe Acute Respiratory Syndrome Treatment Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

* indicates mandatory fields
Our Clients

Request Sample Request customization Request Methodology